| HOME >> BIOLOGY >> TECHNOLOGY |
Changes in operating assets and liabilities:
Other assets 66 105
Accounts payable and accrued liabilities (1,557) 1,072
Deferred rent 1,452 1,443
Net cash used in operating activities (37,651) (32,105)
Investing activities:
Purchases of property and equipment (9,571) (8,586)
Purchases of short-term investments (14,899) (63,386)
Maturities of short-term investments 39,898 58,348
Restricted cash - (1,901)
Net cash provided by (used in) investing
activities 15,428 (15,525)
Financing activities:
Proceeds from debt 6,884 7,563
Payments on debt (6,092) (3,113)
Issuance of common stock and warrants 33,546 45,369
Repurchase of restricted common stock (2) (5)
Net cash provided by financing activities 34,336 49,814
Net increase in cash and cash equivalents 12,113 2,184
Cash and cash equivalents at beginning
of period 14,249 12,065
Cash and cash equivalents at end of period $26,362 $14,249
Supplemental disclosures of cash flow
information:
Cash paid for interest $1,363 $703
Supplemental non-cash activities:
Capitalized interest recorded as property,
plant and equipment $404 $91
Accrued asset acquisitions $(1,670) $1,819
Leasehold improvements acquired
'/>"/>
| SOURCE Favrille, Inc. Copyright©2008 PR Newswire. All rights reserved |